Cellectis Cash Flow Reinvestment Rate
Cellectis cash flow reinvestment rate. Cellectis (ALCLS) has a Cash Flow Reinvestment Rate of 2.06x as of June 2024, reinvesting €107.47 Million (capex €1.04 Million plus investments €-106.43 Million) from operating cash flow of €52.18 Million. Explore ALCLS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cellectis (2005–2024)
Cash flow reinvestment rate of Cellectis from 2005 to 2024. Historical reinvestment intensity for Cellectis across 5 annual periods. Explore ALCLS capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Cellectis Cash Flow Reinvestment Rate by Year (2005–2024)
Cellectis cash flow reinvestment rate by year from 2005 to 2024. Year-by-year capital reinvestment analysis for Cellectis. For the full cash flow conversion analysis, see ALCLS cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.64x | €106.65 Million | €22.99 Million | €3.84 Million | ▲ +263.4% |
| 2015 | 1.28x | €4.52 Million | €3.54 Million | €4.25 Million | ▲ +3184.1% |
| 2014 | 0.04x | €1.97 Million | €50.74 Million | €430.47K | ▼ -91.3% |
| 2008 | 0.44x | €790.71K | €1.78 Million | €790.71K | ▼ -50.8% |
| 2005 | 0.90x | €353.00K | €391.00K | €353.00K | — |